Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

Hey there alphainvestor2,here is a quick breakdown to answer your question:

Phase 3- mst 188 in SCD (EPIC Trial) with completion date Q4 '15
Phase 2- mst 188 in ALI with completion date Q4 '15
Non-clinical study underway for mst 188 in stroke
***about to release data from air001 (recent acquisition from Aires Pharma) if data is positive then Mast should initiate a Phase 2 trial in PAH

There is alot of information available currently on the Mast Website, but if you can wait a week there will be a new presentation available on the Mast Website on 8/14 from their presentation at the Cannacord Genuity Growth Conference in Boston next week.

Hope this quick reply was helpful.

Have a great day....RR